EUROPE ORTHOPEDIC MARKET FORECAST 2017-2024
KEY FINDINGS
The Europe orthopedic market is anticipated to grow $21966 million by 2024. The market growth is expected at the CAGR of 5.94% in the forecast period. The base year considered for the market study is 2016. Acceleration in the cases of musculoskeletal disorders and growing geriatric population are the reason for the growth of the orthopedic market in the region.
MARKET INSIGHTS
The Europe orthopedic market is segmented on the basis of procedure, ortho biologics, and geography. The Europe orthopedic market by the procedure is segmented into arthroscopy, joint reconstruction, HIP, knee, shoulder reconstruction market, soft tissue replacement, spinal surgery procedure. The market by ortho biologics is further segmented into the bone graft, viscosupplementation, one-injection, three-injection, five- injection, stem cells, bone morphogenetic proteins, demineralized bone matrix, allografts and others. The Europe orthopedic market is further segmented into UK, France, Germany, Spain, Italy and rest of Europe. Improved Implant Technologies, increasing Number of Outpatient Techniques, growing Trauma Related Injuries, Age Related Orthopedic Surgeries, increasing Demand for the Elective procedure are the major drivers driving the Orthopedics market. On the other hand, factors restricting the market growth are Stringent Government Policies, Post-Surgery Complications. Growing disposable income across the world is also estimated to be one of the major factors that are creating numerous expansion opportunities for the growth of the orthopedic market. Lack of orthopedic surgeons and High cost of Implants are estimated to be one of the major factors that are restricting the growth of the orthopedic market across the globe.
The Europe orthopedic market is anticipated to grow $21966 million by 2024. The market growth is expected at the CAGR of 5.94% in the forecast period. The base year considered for the market study is 2016. Acceleration in the cases of musculoskeletal disorders and growing geriatric population are the reason for the growth of the orthopedic market in the region.
MARKET INSIGHTS
The Europe orthopedic market is segmented on the basis of procedure, ortho biologics, and geography. The Europe orthopedic market by the procedure is segmented into arthroscopy, joint reconstruction, HIP, knee, shoulder reconstruction market, soft tissue replacement, spinal surgery procedure. The market by ortho biologics is further segmented into the bone graft, viscosupplementation, one-injection, three-injection, five- injection, stem cells, bone morphogenetic proteins, demineralized bone matrix, allografts and others. The Europe orthopedic market is further segmented into UK, France, Germany, Spain, Italy and rest of Europe. Improved Implant Technologies, increasing Number of Outpatient Techniques, growing Trauma Related Injuries, Age Related Orthopedic Surgeries, increasing Demand for the Elective procedure are the major drivers driving the Orthopedics market. On the other hand, factors restricting the market growth are Stringent Government Policies, Post-Surgery Complications. Growing disposable income across the world is also estimated to be one of the major factors that are creating numerous expansion opportunities for the growth of the orthopedic market. Lack of orthopedic surgeons and High cost of Implants are estimated to be one of the major factors that are restricting the growth of the orthopedic market across the globe.
1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
2.5. ESTIMATION METHODOLOGY
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. MARKET DEFINITION AND SCOPE
3.3. KEY FINDINGS
3.3.1. EUROPE BECOMING THE HUB OF MEDICAL RESEARCH
3.3.2. KNEE SURGERIES CONTINUE TO DOMINATE THE MARKET
3.3.3. BIOABSORBABLE IMPLANTS GAINING TRACTION
3.3.4. INCREASE IN R& D EXPENDITURE FOR MSK DISORDERS
4. MARKET OVERVIEW
4.1. MARKET DEFINITION AND SCOPE
4.2. DRIVERS
4.2.1. BETTER IMPLANT TECHNOLOGIES
4.2.2. GROWING NUMBER OF OUTPATIENT TECHNIQUES
4.2.3. RISING TRAUMA RELATED INJURIES
4.2.4. AGE RELATED ORTHOPEDIC SURGERIES
4.2.5. RISING DEMAND FOR ELECTIVE MIS PROCEDURES
4.3. RESTRAINTS
4.3.1. STRINGENT GOVERNMENT POLICIES
4.3.2. POST-SURGERY COMPLICATIONS
4.4. OPPORTUNITIES
4.4.1. BONE REGENERATION TECHNOLOGY
4.4.2. LARGER SPEND ON HEALTHCARE
4.4.3. EMERGING GEOGRAPHIES COMING OF AGE
4.5. CHALLENGES
4.5.1. LACK OF ORTHOPEDIC SURGEONS
4.5.2. HIGH COST OF IMPLANTS
5. EUROPE ORTHOPEDIC MARKET, SEGMENTATION
5.1. BY PROCEDURE
5.1.1. ARTHROSCOPY
5.1.2. JOINT RECONSTRUCTION
5.1.2.1. HIP
5.1.2.2. KNEE
5.1.2.3. SHOULDER RECONSTRUCTION MARKET
5.1.3. SOFT TISSUE REPLACEMENT
5.1.4. SPINAL SURGERY PROCEDURE
5.1.4.1. COMPUTER ASSISTED SURGERY
5.1.4.2. KYPHOPLASTY
5.1.4.3. FUSION & NON-FUSION PROCEDURE
5.2. BY ORTHOBIOLOGICS
5.2.1. BONE GRAFT
5.2.2. VISCOSUPPLEMENTATION
5.2.2.1. ONE-INJECTION
5.2.2.2. THREE-INJECTION
5.2.2.3. FIVE -INJECTION
5.2.3. OTHERS
6. KEY ANALYTICAL
6.1. PORTER’S 5 FORCES ANALYSIS
6.1.1. THREAT OF NEW ENTRANTS
6.1.2. THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
6.1.3. BARGAINING POWER OF BUYER
6.1.4. BARGAINING POWER OF SUPPLIER
6.1.5. INTENSITY OF COMPETITIVE RIVALRY
6.2. KEY BUYING CRITERIA
6.3. INVESTMENT ANALYSIS
6.4. KEY MARKET INSIGHTS
6.4.1. IMPORTANT GEOGRAPHIES
6.5. OPPORTUNITY MATRIX
6.5.1. FAST GROWING SEGMENTS
7. EUROPE ANALYSIS
7.1. EUROPE ORTHOPEDIC MARKET
7.1.1. UNITED KINGDOM ORTHOPEDIC MARKET
7.1.2. FRANCE ORTHOPEDIC MARKET
7.1.3. GERMANY ORTHOPEDIC MARKET
7.1.4. SPAIN ORTHOPEDIC MARKET
7.1.5. ITALY ORTHOPEDIC MARKET
7.1.6. REST OF EUROPE
8. COMPETITIVE LANDSCAPE
8.1. MARKET SHARE ANALYSIS
8.2. STRATEGIC MOVES
8.2.1. MERGERS & ACQUISITIONS
9. COMPANY PROFILES
9.1. AAP IMPLANTATE AG
9.1.1. OVERVIEW
9.1.2. PRODUCT PORTFOLIO
9.1.3. SCOT
9.1.4. STRATEGIC ANALYSIS
9.2. AMEDICA CORPORATION
9.2.1. OVERVIEW
9.2.2. PRODUCT PORTFOLIO
9.2.3. STRATEGIC INITIATIVES
9.2.4. SCOT
9.2.5. STRATEGIC ANALYSIS
9.3. ARTHROCARE CORPORATION (ACQUIRED BY SMITH AND NEPHEW)
9.3.1. OVERVIEW
9.4. BIOMET INC (MERGE WITH ZIMMER)
9.4.1. OVERVIEW
9.5. CONMED CORPORATION
9.5.1. OVERVIEW
9.5.2. PRODUCT PORTFOLIO
9.5.3. STRATEGIC INITIATIVES
9.5.4. SCOT
9.5.5. ANALYSIS
9.6. DEPUY INC (ACQUIRED BY JOHNSON AND JOHNSON)
9.6.1. OVERVIEW
9.6.2. PRODUCT PORTFOLIO
9.6.3. STRATEGIC INITIATIVES
9.6.4. STRATEGIC ANALYSIS
9.7. EXATECH INC
9.7.1. OVERVIEW
9.7.2. PRODUCT PORTFOLIO
9.7.3. SCOT
9.7.4. STRATEGIC ANALYSIS
9.8. GLOBUS MEDICAL INC
9.8.1. OVERVIEW
9.8.2. PRODUCT PORTFOLIO
9.8.3. STRATEGIC INITIATIVES
9.8.4. SCOT
9.8.5. STRATEGIC ANALYSIS
9.9. INTEGRA LIFESCIENCES HOLDING CORPORATION
9.9.1. OVERVIEW
9.9.2. PRODUCT PORTFOLIO
9.9.3. STRATEGIC INITIATIVES
9.9.4. SCOT ANALYSIS
9.9.5. STRATEGIC ANALYSIS
9.10. MEDTRONIC INC
9.10.1. OVERVIEW
9.10.2. PRODUCT PORTFOLIO
9.10.3. STRATEGIC INITIATIVES
9.10.4. SCOT
9.10.5. STRATEGIC ANALYSIS
9.11. NUVASIVE INC
9.11.1. OVERVIEW
9.11.2. PRODUCT PORTFOLIO
9.11.3. STRATEGIC INITIATIVES
9.11.4. SCOT ANALYSIS
9.11.5. STRATEGIC ANALYSIS
9.12. SMITH & NEPHEW PLC
9.12.1. OVERVIEW
9.12.2. PRODUCT PORTFOLIO
9.12.3. STRATEGIC INITIATIVES
9.12.4. SCOT
9.12.5. STRATEGIC ANALYSIS
9.13. STRYKER CORPORATION
9.13.1. OVERVIEW
9.13.1.1. PRODUCT PORTFOLIO
9.13.1.2. STRATEGIC INITIATIVES
9.13.1.3. SCOT ANALYSIS
9.13.1.4. STRATEGIC ANALYSIS
9.13.2. SYNTHES INC (ACQUIRED BY JOHNSON AND JOHNSON)
9.13.2.1. OVERVIEW
9.13.3. ZIMMER BIOMET INC
9.13.3.1. OVERVIEW
9.13.3.2. PRODUCT PORTFOLIO
9.13.3.3. STRATEGIC INITIATIVES
9.13.3.4. SCOT ANALYSIS
9.13.3.5. STRATEGIC ANALYSIS
TABLE LIST
TABLE 1 EUROPE ORTHOPEDIC MARKET, 2017-2024 ($ MILLION)
TABLE 2 POST SURGERY ISSUES
TABLE 3 AVERAGE COST OF ORTHOPEDIC SURGERY IMPLANTS ($)
TABLE 4 EUROPEORTHOPEDIC MARKET BY PROCEDURE 2017-2024 ($MILLION)
TABLE 5 EUROPEORTHOPEDIC MARKET OF ARTHROSCOPY BY GEOGRAPHY 2017-2024 ($MILLION)
TABLE 6 EUROPEORTHOPEDIC MARKET OF JOINT RECONSTRUCTION BY GEOGRAPHY 2017-2024 ($MILLION)
TABLE 7 EUROPEORTHOPEDIC MARKET BY HIP RECONSTRUCTIONBY GEOGRAPHY 2017-2024 ($MILLION)
TABLE 8 EUROPEORTHOPEDIC MARKET BY KNEE RECONSTRUCTION BY GEOGRAPHY 2017-2024 ($MILLION)
TABLE 9 EUROPEORTHOPEDIC MARKET OF SHOULDER RECONSTRUCTION BY GEOGRAPHY 2017-2024 ($ MILLION)
TABLE 10 EUROPEORTHOPEDIC MARKET BYSOFT TISSUE REPLACEMENT BY GEOGRAPHY 2017-2024 ($MILLION)
TABLE 11 EUROPEORTHOPEDIC MARKET BY SPINAL SURGERY PROCEDURE 2017-2024 ($MILLION)
TABLE 12 EUROPEORTHOPEDIC MARKET BY COMPURTER ASSISTED SURGERY BY GEOGRAPHY 2017-2024 ($MILLION)
TABLE 13 EUROPEORTHOPEDIC MARKET BY KYPHOPLASTY2017-2024 ($MILLION)
TABLE 14 EUROPEORTHOPEDIC MARKET (FUSION AND NON-FUSION PROCEDURE) BY GEOGRAPHY 2017-2024 ($ MILLION)
TABLE 15 EUROPEORTHOPEDIC MARKET BY ORTHOBILOLOGICS 2017-2024 ($ MILLION)
TABLE 16 SINGLE INJECTION IN VISCOSUPPLEMENTATION COST AND DIFFERENT BRAND
TABLE 17 THREE-INJECTION MARKET, BY EUROPE 2017–2024($ MILLION)
TABLE 18 MULTIPLE INJECTIONS IN VISCOSUPPLEMENTATION
TABLE 19 FIVE-INJECTION MARKET, BY EUROPE 2017–2024($ MILLION)
TABLE 20EUROPE POPULATION AGE STRUCTURE BY AGE GROUP 2015
TABLE 21EUROPE ORTHOPEDIC MARKET 2017-2024 ($ MILLION)
FIGURES LIST
FIGURE 1 EUROPE ORTHOPEDIC MARKET BY PROCEDURE 2017-2024 ($ MILLION)
FIGURE 2 MUSCULOSKELETAL RELATED CONDITIONS, DISEASES AND RESEARCH AREAS FUNDED BY
FIGURE 3MUSCULOSKELETAL RELATED CONDITIONS, DISEASES AND RESEARCH AREAS FUNDED BY NIH, 2009-2013
FIGURE 4INCREASING DEMAND OF MINIMAL INVASIVE TECHNOLOGIES 2010-2025 ($ MILLION)
FIGURE 5GROWING DISPOSABLE INCOME ACROSS THE WORLD 2014 & 2015 ($)
FIGURE 6EUROPEORTHOPEDIC MARKET OF ARTHROSCOPY BY GEOGRAPHY 2017-2024 ($ MILLION)
FIGURE 7EUROPEORTHOPEDIC MARKET OF JOINT RECONSTRUCTION2017-2024 ($MILLION)
FIGURE 8EUROPEORTHOPEDIC MARKET BY HIP RECONSTRUCTION 2017-2024 ($ MILLION)
FIGURE 9EUROPEORTHOPEDIC MARKET BY KNEE RECONSTRUCTION 2017-2024 ($ MILLION
FIGURE 10EUROPEORTHOPEDIC MARKET OF SHOULDER RECONSTRUCTION BY GEOGRAPHY 2017-2024 ($ MILLION)
FIGURE 11EUROPEORTHOPEDIC MARKET BY SOFT TISSUE REPLACEMENT 2017-2024 ($MILLION)
FIGURE 12EUROPEORTHOPEDIC MARKET BY SPINAL SURGERY PROCEDURE 2017-2024 ($MILLION)
FIGURE 13EUROPEORTHOPEDIC MARKET BY COMPURTER ASSISTED SURGERY2017-2024 ($ MILLION)
FIGURE 14EUROPEORTHOPEDIC MARKET BY KYPHOPLASTY2017-2024 ($MILLION)
FIGURE 15EUROPEORTHOPEDIC MARKET BY FUSION AND NON FUSION PROCEDURE 2017-2024 ($ MILLION)
FIGURE 16EUROPEORTHOPEDICS MARKET BY BONE GRAFT BY GEOGRAPY 2017-2024 ($MILLION)
FIGURE 17EUROPE ORTHOPEADICS MARKET BY OTHER ORTHOBIOLOGICS BY VISCOSUPPLEMENTATION 2017-2024 ($MILLION)
FIGURE 18EUROPE VISCOSUPPLEMENTATION ONE-INJECTION MARKET REVENUE 2017–2024($ MILLION)
FIGURE 19EUROPE VISCOSUPPLEMENTATION THREE-INJECTION MARKET REVENUE BY EUROPE, 2017–2024($ MILLION)
FIGURE 20EUROPE VISCOSUPPLEMENTATION FIVE-INJECTION MARKET REVENUE BY EUROPE 2017–2024($ MILLION)
FIGURE 21EUROPE ORTHOPEADICS MARKET BY OTHER ORTHOBIOLOGICS BY GEOGRAPHY 2017-2024 ($MILLION)
FIGURE 22EUROPE ORTHOPEADICS MARKET BY OTHER ORTHOBIOLOGICS BY GEOGRAPHY 2017-2024 ($MILLION)
FIGURE 23 PERSON AGED ABOVE 65 YEARS EXTRAPOLATED 2013-2040 (MILLION)
FIGURE 24 EUROPE ORTHOPEDIC MARKET BY COUNTRY 2016 & 2024 (% SHARE)
FIGURE 25 UNITED KINGDOM (UK) ORTHOPEDIC MARKET 2017-2024 ($ MILLION)
FIGURE 26 POPULATION AGED 65 AND ABOVE IN FRANCE IN 2012 & 2015 (%)
FIGURE 27 FRANCE ORTHOPEDIC MARKET 2017-2024 ($ MILLION)
FIGURE 28 AGE STRUCTURE OF GERMANY 2015
FIGURE 29 POPULATION AGED ABOVE 65 YEARS 2005 & 2015 (% OF POPULATION)
FIGURE 30 GERMANY ORTHOPEDIC MARKET 2017-2024 ($ MILLION)
FIGURE 31 HEALTHCARE FACTS OF SPAIN 2015
FIGURE 32 AGING POPULATION IN SPAIN 2005 AND 2015 (%)
FIGURE 33 SPAIN ORTHOPEDIC MARKET 2017-2024 ($ MILLION)
FIGURE 34 AGING POPULATION IN ITALY 2005 AND 2015 (%)
FIGURE 35 ITALY ORTHOPEDIC MARKET 2017-2024 ($ MILLION)
FIGURE 36 POPULATION AGED ABOVE 65 YEARS ACROSS COUNTRIES 2015 (% TOTAL POPULATION)
FIGURE 37 ROE ORTHOPEDIC MARKET 2017-2024 ($ MILLION)
FIGURE 38 GROWING AGING POPULATION RATE, 2010 AND 2050
FIGURE 39 MARKET SHARE OF ORTHOPEDIC COMPANIES WITH MARKET SHARE 2016 (%)
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
2.5. ESTIMATION METHODOLOGY
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. MARKET DEFINITION AND SCOPE
3.3. KEY FINDINGS
3.3.1. EUROPE BECOMING THE HUB OF MEDICAL RESEARCH
3.3.2. KNEE SURGERIES CONTINUE TO DOMINATE THE MARKET
3.3.3. BIOABSORBABLE IMPLANTS GAINING TRACTION
3.3.4. INCREASE IN R& D EXPENDITURE FOR MSK DISORDERS
4. MARKET OVERVIEW
4.1. MARKET DEFINITION AND SCOPE
4.2. DRIVERS
4.2.1. BETTER IMPLANT TECHNOLOGIES
4.2.2. GROWING NUMBER OF OUTPATIENT TECHNIQUES
4.2.3. RISING TRAUMA RELATED INJURIES
4.2.4. AGE RELATED ORTHOPEDIC SURGERIES
4.2.5. RISING DEMAND FOR ELECTIVE MIS PROCEDURES
4.3. RESTRAINTS
4.3.1. STRINGENT GOVERNMENT POLICIES
4.3.2. POST-SURGERY COMPLICATIONS
4.4. OPPORTUNITIES
4.4.1. BONE REGENERATION TECHNOLOGY
4.4.2. LARGER SPEND ON HEALTHCARE
4.4.3. EMERGING GEOGRAPHIES COMING OF AGE
4.5. CHALLENGES
4.5.1. LACK OF ORTHOPEDIC SURGEONS
4.5.2. HIGH COST OF IMPLANTS
5. EUROPE ORTHOPEDIC MARKET, SEGMENTATION
5.1. BY PROCEDURE
5.1.1. ARTHROSCOPY
5.1.2. JOINT RECONSTRUCTION
5.1.2.1. HIP
5.1.2.2. KNEE
5.1.2.3. SHOULDER RECONSTRUCTION MARKET
5.1.3. SOFT TISSUE REPLACEMENT
5.1.4. SPINAL SURGERY PROCEDURE
5.1.4.1. COMPUTER ASSISTED SURGERY
5.1.4.2. KYPHOPLASTY
5.1.4.3. FUSION & NON-FUSION PROCEDURE
5.2. BY ORTHOBIOLOGICS
5.2.1. BONE GRAFT
5.2.2. VISCOSUPPLEMENTATION
5.2.2.1. ONE-INJECTION
5.2.2.2. THREE-INJECTION
5.2.2.3. FIVE -INJECTION
5.2.3. OTHERS
6. KEY ANALYTICAL
6.1. PORTER’S 5 FORCES ANALYSIS
6.1.1. THREAT OF NEW ENTRANTS
6.1.2. THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
6.1.3. BARGAINING POWER OF BUYER
6.1.4. BARGAINING POWER OF SUPPLIER
6.1.5. INTENSITY OF COMPETITIVE RIVALRY
6.2. KEY BUYING CRITERIA
6.3. INVESTMENT ANALYSIS
6.4. KEY MARKET INSIGHTS
6.4.1. IMPORTANT GEOGRAPHIES
6.5. OPPORTUNITY MATRIX
6.5.1. FAST GROWING SEGMENTS
7. EUROPE ANALYSIS
7.1. EUROPE ORTHOPEDIC MARKET
7.1.1. UNITED KINGDOM ORTHOPEDIC MARKET
7.1.2. FRANCE ORTHOPEDIC MARKET
7.1.3. GERMANY ORTHOPEDIC MARKET
7.1.4. SPAIN ORTHOPEDIC MARKET
7.1.5. ITALY ORTHOPEDIC MARKET
7.1.6. REST OF EUROPE
8. COMPETITIVE LANDSCAPE
8.1. MARKET SHARE ANALYSIS
8.2. STRATEGIC MOVES
8.2.1. MERGERS & ACQUISITIONS
9. COMPANY PROFILES
9.1. AAP IMPLANTATE AG
9.1.1. OVERVIEW
9.1.2. PRODUCT PORTFOLIO
9.1.3. SCOT
9.1.4. STRATEGIC ANALYSIS
9.2. AMEDICA CORPORATION
9.2.1. OVERVIEW
9.2.2. PRODUCT PORTFOLIO
9.2.3. STRATEGIC INITIATIVES
9.2.4. SCOT
9.2.5. STRATEGIC ANALYSIS
9.3. ARTHROCARE CORPORATION (ACQUIRED BY SMITH AND NEPHEW)
9.3.1. OVERVIEW
9.4. BIOMET INC (MERGE WITH ZIMMER)
9.4.1. OVERVIEW
9.5. CONMED CORPORATION
9.5.1. OVERVIEW
9.5.2. PRODUCT PORTFOLIO
9.5.3. STRATEGIC INITIATIVES
9.5.4. SCOT
9.5.5. ANALYSIS
9.6. DEPUY INC (ACQUIRED BY JOHNSON AND JOHNSON)
9.6.1. OVERVIEW
9.6.2. PRODUCT PORTFOLIO
9.6.3. STRATEGIC INITIATIVES
9.6.4. STRATEGIC ANALYSIS
9.7. EXATECH INC
9.7.1. OVERVIEW
9.7.2. PRODUCT PORTFOLIO
9.7.3. SCOT
9.7.4. STRATEGIC ANALYSIS
9.8. GLOBUS MEDICAL INC
9.8.1. OVERVIEW
9.8.2. PRODUCT PORTFOLIO
9.8.3. STRATEGIC INITIATIVES
9.8.4. SCOT
9.8.5. STRATEGIC ANALYSIS
9.9. INTEGRA LIFESCIENCES HOLDING CORPORATION
9.9.1. OVERVIEW
9.9.2. PRODUCT PORTFOLIO
9.9.3. STRATEGIC INITIATIVES
9.9.4. SCOT ANALYSIS
9.9.5. STRATEGIC ANALYSIS
9.10. MEDTRONIC INC
9.10.1. OVERVIEW
9.10.2. PRODUCT PORTFOLIO
9.10.3. STRATEGIC INITIATIVES
9.10.4. SCOT
9.10.5. STRATEGIC ANALYSIS
9.11. NUVASIVE INC
9.11.1. OVERVIEW
9.11.2. PRODUCT PORTFOLIO
9.11.3. STRATEGIC INITIATIVES
9.11.4. SCOT ANALYSIS
9.11.5. STRATEGIC ANALYSIS
9.12. SMITH & NEPHEW PLC
9.12.1. OVERVIEW
9.12.2. PRODUCT PORTFOLIO
9.12.3. STRATEGIC INITIATIVES
9.12.4. SCOT
9.12.5. STRATEGIC ANALYSIS
9.13. STRYKER CORPORATION
9.13.1. OVERVIEW
9.13.1.1. PRODUCT PORTFOLIO
9.13.1.2. STRATEGIC INITIATIVES
9.13.1.3. SCOT ANALYSIS
9.13.1.4. STRATEGIC ANALYSIS
9.13.2. SYNTHES INC (ACQUIRED BY JOHNSON AND JOHNSON)
9.13.2.1. OVERVIEW
9.13.3. ZIMMER BIOMET INC
9.13.3.1. OVERVIEW
9.13.3.2. PRODUCT PORTFOLIO
9.13.3.3. STRATEGIC INITIATIVES
9.13.3.4. SCOT ANALYSIS
9.13.3.5. STRATEGIC ANALYSIS
TABLE LIST
TABLE 1 EUROPE ORTHOPEDIC MARKET, 2017-2024 ($ MILLION)
TABLE 2 POST SURGERY ISSUES
TABLE 3 AVERAGE COST OF ORTHOPEDIC SURGERY IMPLANTS ($)
TABLE 4 EUROPEORTHOPEDIC MARKET BY PROCEDURE 2017-2024 ($MILLION)
TABLE 5 EUROPEORTHOPEDIC MARKET OF ARTHROSCOPY BY GEOGRAPHY 2017-2024 ($MILLION)
TABLE 6 EUROPEORTHOPEDIC MARKET OF JOINT RECONSTRUCTION BY GEOGRAPHY 2017-2024 ($MILLION)
TABLE 7 EUROPEORTHOPEDIC MARKET BY HIP RECONSTRUCTIONBY GEOGRAPHY 2017-2024 ($MILLION)
TABLE 8 EUROPEORTHOPEDIC MARKET BY KNEE RECONSTRUCTION BY GEOGRAPHY 2017-2024 ($MILLION)
TABLE 9 EUROPEORTHOPEDIC MARKET OF SHOULDER RECONSTRUCTION BY GEOGRAPHY 2017-2024 ($ MILLION)
TABLE 10 EUROPEORTHOPEDIC MARKET BYSOFT TISSUE REPLACEMENT BY GEOGRAPHY 2017-2024 ($MILLION)
TABLE 11 EUROPEORTHOPEDIC MARKET BY SPINAL SURGERY PROCEDURE 2017-2024 ($MILLION)
TABLE 12 EUROPEORTHOPEDIC MARKET BY COMPURTER ASSISTED SURGERY BY GEOGRAPHY 2017-2024 ($MILLION)
TABLE 13 EUROPEORTHOPEDIC MARKET BY KYPHOPLASTY2017-2024 ($MILLION)
TABLE 14 EUROPEORTHOPEDIC MARKET (FUSION AND NON-FUSION PROCEDURE) BY GEOGRAPHY 2017-2024 ($ MILLION)
TABLE 15 EUROPEORTHOPEDIC MARKET BY ORTHOBILOLOGICS 2017-2024 ($ MILLION)
TABLE 16 SINGLE INJECTION IN VISCOSUPPLEMENTATION COST AND DIFFERENT BRAND
TABLE 17 THREE-INJECTION MARKET, BY EUROPE 2017–2024($ MILLION)
TABLE 18 MULTIPLE INJECTIONS IN VISCOSUPPLEMENTATION
TABLE 19 FIVE-INJECTION MARKET, BY EUROPE 2017–2024($ MILLION)
TABLE 20EUROPE POPULATION AGE STRUCTURE BY AGE GROUP 2015
TABLE 21EUROPE ORTHOPEDIC MARKET 2017-2024 ($ MILLION)
FIGURES LIST
FIGURE 1 EUROPE ORTHOPEDIC MARKET BY PROCEDURE 2017-2024 ($ MILLION)
FIGURE 2 MUSCULOSKELETAL RELATED CONDITIONS, DISEASES AND RESEARCH AREAS FUNDED BY
FIGURE 3MUSCULOSKELETAL RELATED CONDITIONS, DISEASES AND RESEARCH AREAS FUNDED BY NIH, 2009-2013
FIGURE 4INCREASING DEMAND OF MINIMAL INVASIVE TECHNOLOGIES 2010-2025 ($ MILLION)
FIGURE 5GROWING DISPOSABLE INCOME ACROSS THE WORLD 2014 & 2015 ($)
FIGURE 6EUROPEORTHOPEDIC MARKET OF ARTHROSCOPY BY GEOGRAPHY 2017-2024 ($ MILLION)
FIGURE 7EUROPEORTHOPEDIC MARKET OF JOINT RECONSTRUCTION2017-2024 ($MILLION)
FIGURE 8EUROPEORTHOPEDIC MARKET BY HIP RECONSTRUCTION 2017-2024 ($ MILLION)
FIGURE 9EUROPEORTHOPEDIC MARKET BY KNEE RECONSTRUCTION 2017-2024 ($ MILLION
FIGURE 10EUROPEORTHOPEDIC MARKET OF SHOULDER RECONSTRUCTION BY GEOGRAPHY 2017-2024 ($ MILLION)
FIGURE 11EUROPEORTHOPEDIC MARKET BY SOFT TISSUE REPLACEMENT 2017-2024 ($MILLION)
FIGURE 12EUROPEORTHOPEDIC MARKET BY SPINAL SURGERY PROCEDURE 2017-2024 ($MILLION)
FIGURE 13EUROPEORTHOPEDIC MARKET BY COMPURTER ASSISTED SURGERY2017-2024 ($ MILLION)
FIGURE 14EUROPEORTHOPEDIC MARKET BY KYPHOPLASTY2017-2024 ($MILLION)
FIGURE 15EUROPEORTHOPEDIC MARKET BY FUSION AND NON FUSION PROCEDURE 2017-2024 ($ MILLION)
FIGURE 16EUROPEORTHOPEDICS MARKET BY BONE GRAFT BY GEOGRAPY 2017-2024 ($MILLION)
FIGURE 17EUROPE ORTHOPEADICS MARKET BY OTHER ORTHOBIOLOGICS BY VISCOSUPPLEMENTATION 2017-2024 ($MILLION)
FIGURE 18EUROPE VISCOSUPPLEMENTATION ONE-INJECTION MARKET REVENUE 2017–2024($ MILLION)
FIGURE 19EUROPE VISCOSUPPLEMENTATION THREE-INJECTION MARKET REVENUE BY EUROPE, 2017–2024($ MILLION)
FIGURE 20EUROPE VISCOSUPPLEMENTATION FIVE-INJECTION MARKET REVENUE BY EUROPE 2017–2024($ MILLION)
FIGURE 21EUROPE ORTHOPEADICS MARKET BY OTHER ORTHOBIOLOGICS BY GEOGRAPHY 2017-2024 ($MILLION)
FIGURE 22EUROPE ORTHOPEADICS MARKET BY OTHER ORTHOBIOLOGICS BY GEOGRAPHY 2017-2024 ($MILLION)
FIGURE 23 PERSON AGED ABOVE 65 YEARS EXTRAPOLATED 2013-2040 (MILLION)
FIGURE 24 EUROPE ORTHOPEDIC MARKET BY COUNTRY 2016 & 2024 (% SHARE)
FIGURE 25 UNITED KINGDOM (UK) ORTHOPEDIC MARKET 2017-2024 ($ MILLION)
FIGURE 26 POPULATION AGED 65 AND ABOVE IN FRANCE IN 2012 & 2015 (%)
FIGURE 27 FRANCE ORTHOPEDIC MARKET 2017-2024 ($ MILLION)
FIGURE 28 AGE STRUCTURE OF GERMANY 2015
FIGURE 29 POPULATION AGED ABOVE 65 YEARS 2005 & 2015 (% OF POPULATION)
FIGURE 30 GERMANY ORTHOPEDIC MARKET 2017-2024 ($ MILLION)
FIGURE 31 HEALTHCARE FACTS OF SPAIN 2015
FIGURE 32 AGING POPULATION IN SPAIN 2005 AND 2015 (%)
FIGURE 33 SPAIN ORTHOPEDIC MARKET 2017-2024 ($ MILLION)
FIGURE 34 AGING POPULATION IN ITALY 2005 AND 2015 (%)
FIGURE 35 ITALY ORTHOPEDIC MARKET 2017-2024 ($ MILLION)
FIGURE 36 POPULATION AGED ABOVE 65 YEARS ACROSS COUNTRIES 2015 (% TOTAL POPULATION)
FIGURE 37 ROE ORTHOPEDIC MARKET 2017-2024 ($ MILLION)
FIGURE 38 GROWING AGING POPULATION RATE, 2010 AND 2050
FIGURE 39 MARKET SHARE OF ORTHOPEDIC COMPANIES WITH MARKET SHARE 2016 (%)
